Fatigue, a common symptom presenting in clinical practice, often poses a diagnostic challenge to healthcare professionals. It is a multidimensional phenomenon with physical, cognitive, and emotional components, often associated with a variety of medical conditions.
Fatigue can be classified into primary and secondary types. Primary fatigue, being idiopathic in nature, is not associated with any underlying medical condition. Secondary fatigue, on the other hand, is attributable to identifiable medical conditions such as anemia, hypothyroidism, or chronic diseases.
Comprehensive clinical assessment is crucial in diagnosing fatigue. A thorough history taking should focus on the onset, duration, severity, and impact on daily activities. Physical examination and appropriate laboratory tests are essential to rule out underlying medical conditions.
Management of fatigue involves treating the underlying cause, if identified. In cases of primary fatigue, a multidisciplinary approach involving cognitive-behavioral therapy, graded exercise therapy, and pharmacological interventions may be beneficial. Patient education and self-management strategies play a crucial role in managing this complex symptom.
Recent research focuses on understanding the pathophysiology of fatigue and developing novel therapeutic strategies. Advances in neuroimaging and molecular biology promise to unravel the complexity of fatigue and offer new avenues for treatment.
Fatigue is a complex symptom with multifactorial etiology. A comprehensive clinical approach is vital to diagnose and manage this condition effectively. Ongoing research and advancements in biomedical technology hold promise for better understanding and management of fatigue in the future.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation